Search Nonprofits

METAvivor is dedicated to the specific fight of women and men living with stage 4 metastatic breast cancer. At the time of METAvivor’s founding, no organization was dedicated to funding research for the disease and no patient groups were speaking out about the dearth of stage 4 cancer research. While more and more people have taken up the cry for more stage 4 research, METAvivor remains the sole US organization dedicated to awarding annual stage 4 breast cancer research.

Mission: To facilitate global collaboration and fund world-class research, medical education, and treatment trials, that make a positive impact on the lives of people with ME/CFS, Long COVID and related diseases. Vision: Significantly improve patient outcomes while advancing a cure. Goals: Our primary goals are to: frame clear disease mechanisms and models; find effective treatments and diagnostic markers; increase accurate diagnoses; and ensure access to quality care.

Our mission is to provide sport and physical activity opportunities for individuals who are blind or visually impaired.

Founded in 1910, the Center for Hearing and Communication is the oldest and largest nonprofit organization providing comprehensive hearing rehabilitation and social services programs for individuals who are deaf or have hearing loss. With locations in New York and Florida, we continue to expand and enhance services for the deal/hard of hearing community, while adhering to our mission by providing services regardless of age, ability to pay, or mode of communication.

Our mission is to extend and improve the lives of those affected by pulmonary hypertension (PH). Our vision is a world without PH, empowered by hope.

Mission MSA (formerly the Multiple System Atrophy Coalition) is a positive beacon of hope standing up to a little known, rare, insidious disorder. Mission MSA has a primary purpose of assisting researchers to find a cure. In the meantime, Mission MSA also provides much needed patient and caregiver support, educational resources, and advocacy to create awareness and to fight for issues important to the MSA community. F/K/A The Multiple System Atrophy Coalition

Wellness in the Schools is a national non-profit that teaches kids healthy habits to learn and live better. We partner with public schools to provide nutrition and fitness education, healthy scratch-cooked meals and active recess periods. Our approach improves student outcomes and drives systemic, long-term change, shifting school cultures.

Little City is dedicated to serving children and adults with intellectual and developmental disabilities by providing the best options and opportunities to live safely, learn continuously, explore creatively and work productively throughout their lifetime. By inspiring, advocating and pursuing success with passion and purpose, lives are changed through hope, happiness, and optimism.

To improve the lives of persons affected by myositis, fund innovative research and increase myositis awareness and advocacy.

Our mission is to advance the awareness and treatment of Angelman Syndrome through education and information, research, advocacy, and support for individuals with Angelman Syndrome, their families, and other concerned parties.

For more than 35 years, HospiceCare in The Berkshires (HCIB) has been caring for generations of our neighbors throughout Berkshire County, providing support and care for those living with a life-limiting illness. Our compassionate team guides families through this emotionally challenging time with information, resources, and expert medical care for the best possible quality of life.

Our mission is to find a effective treatments and ultimately a cure for fragile X syndrome, the most common inherited cause of autism. We directly fund research grants and fellowships at top universities around the world. FRAXA was founded in 1994 by three parents of children with fragile X. Fragile X Syndrome is the most common inherited cause of autism and intellectual disabilities. It affects 1 in 4000 boys and 1 in 6000 girls worldwide, and one in 260 women and 1 in 800 men are carriers. Treatments for fragile X are likely to help people affected by related disorders including autism, Alzheimers, and many other brain disorders.